| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Venrock Adviser, LLC | $130.3M | 6.5M | ▼−3.8% Reduced · −255K sh | Q1 2026 | |
| 2 | Frazier Life Sciences Management, L.P. | $99.9M | 5.0M | ▼−1.6% Reduced · −79K sh | Q1 2026 | |
| 3 | SUVRETTA CAPITAL MANAGEMENT, LLC | $96.0M | 4.8M | —Held | Q1 2026 | |
| 4 | TANG CAPITAL MANAGEMENT LLC | $92.1M | 4.6M | —Held | Q1 2026 | |
| 5 | BlackRock, Inc. | $76.4M | 3.8M | ▲+1.1% Added · +42K sh | Q1 2026 | |
| 6 | Point72 Asset Management, L.P. | $43.0M | 2.1M | ▼−6.4% Reduced · −147K sh | Q1 2026 | |
| 7 | STATE STREET CORP | $39.4M | 2.0M | ▲+2.3% Added · +44K sh | Q1 2026 | |
| 8 | MILLENNIUM MANAGEMENT LLC | $38.5M | 1.9M | ▼−34% Reduced · −985K sh | Q1 2026 | |
| 9 | Vestal Point Capital, LP | $37.2M | 1.9M | ▼−2.1% Reduced · −40K sh | Q1 2026 | |
| 10 | Parkman Healthcare Partners LLC | $36.9M | 1.8M | ▲+3.8% Added · +67K sh | Q1 2026 | |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | $36.8M | 1.8M | ▲New +1.8M sh | Q1 2026 | |
| 12 | Kynam Capital Management, LP | $36.7M | 1.8M | ▲+0.6% Added · +10K sh | Q1 2026 | |
| 13 | Woodline Partners LP | $30.4M | 1.5M | ▼−21% Reduced · −411K sh | Q1 2026 | |
| 14 | Octagon Capital Advisors LP | $29.2M | 1.4M | ▲+14% Added · +177K sh | Q1 2026 | |
| 15 | EMERALD ADVISERS, LLC | $25.4M | 1.3M | ▼−5.7% Reduced · −76K sh | Q1 2026 | |
| 16 | ARMISTICE CAPITAL, LLC | $24.9M | 1.2M | ▲+55% Added · +436K sh | Q1 2026 | |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | $20.1M | 996K | ▲+5.5% Added · +52K sh | Q1 2026 | |
| 18 | Squadron Capital Management LLC | $19.8M | 985K | ▲+41% Added · +285K sh | Q1 2026 | |
| 19 | Freestone Grove Partners LP | $17.8M | 883K | ▲+39% Added · +250K sh | Q1 2026 | |
| 20 | GOLDMAN SACHS GROUP INC | $16.6M | 824K | ▼−1.3% Reduced · −11K sh | Q1 2026 | |
| 21 | EMERALD MUTUAL FUND ADVISERS TRUST | $16.2M | 806K | ▼−5.8% Reduced · −50K sh | Q1 2026 | |
| 22 | GREAT POINT PARTNERS LLC | $13.6M | 675K | ▼−1.6% Reduced · −11K sh | Q1 2026 | |
| 23 | Bank of New York Mellon Corp | $11.8M | 584K | ▼−16% Reduced · −111K sh | Q1 2026 | |
| 24 | BANK OF AMERICA CORP /DE/ | $11.2M | 556K | ▲+43% Added · +166K sh | Q1 2026 | |
| 25 | BARCLAYS PLC | $10.8M | 537K | ▼−23% Reduced · −164K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| BOSTON SCIENTIFIC CORPBSX | 54 funds | $1.8B |
| MICROSOFT CORPMSFT | 53 funds | $20.1B |
| AMAZON.COM INCAMZN | 53 funds | $15.4B |
| BROADCOM INCAVGO | 53 funds | $12.7B |
| META PLATFORMS INC-CLASS AMETA | 53 funds | $9.5B |
| ELI LILLY & COLLY | 53 funds | $5.4B |
| UNITEDHEALTH GROUP INCUNH | 52 funds | $2.4B |
| BRISTOL-MYERS SQUIBB COBMY | 52 funds | $1.9B |
| STRYKER CORPSYK | 52 funds | $698.9M |
| NVIDIA CORPNVDA | 51 funds | $31.5B |
| ALPHABET INC-CL AGOOGL | 51 funds | $12.8B |
| MICRON TECHNOLOGY INCMU | 51 funds | $5.8B |
Ranked by how many of KALV's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell (S) | 34K | $905K |
| May 26, 2026 | Sweeny Nicole | Chief Commercial Officer | Sell (S) | 1K | $40K |
| May 26, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell (S) | 2K | $53K |
| May 26, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell (S) | 2K | $60K |
| May 22, 2026 | Sweeny Nicole | Chief Commercial Officer | Sell (S) | 2K | $50K |
| May 22, 2026 | Piekos Brian | Chief Financial Officer | Sell (S) | 1K | $40K |
| May 22, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell (S) | 2K | $63K |
| May 22, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER, Director | Sell (S) | 11K | $293K |
| May 22, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell (S) | 3K | $72K |
| May 18, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell (S) | 1K | $30K |
| May 18, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER, Director | Sell (S) | 1K | $30K |
| May 18, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell (S) | 1K | $28K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/KALV/capital-change-brief"
Use Arkolith's capital_change_brief for KALV. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for KALV. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.